Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum heme polymerization complex is a vital biochemical system responsible for the detoxification of free heme within the malaria parasite's digestive vacuole (Jani et al., 2008, PLoS Pathogens). During the intraerythrocytic stage of its life cycle, the parasite degrades host hemoglobin to obtain essential amino acids, a process that releases ferriprotoporphyrin IX (heme). Because free heme is highly toxic and can cause oxidative damage to membranes and proteins, the parasite converts it into an insoluble, inert crystalline polymer called hemozoin (Egan, 2008, J Inorg Biochem). This biocrystallization is facilitated by the Heme Detoxification Protein (HDP), which is considered one of the most efficient catalysts for this reaction (Jani et al., 2008, PLoS Pathogens). This pathway is the primary target for many classic antimalarial drugs, including chloroquine and quinine, which bind to heme or the growing crystal surface to inhibit further polymerization (Slater & Cerami, 1992, Nature). The resulting accumulation of toxic heme leads to the destruction of the parasite. However, the emergence of resistance, mediated by mutations in transporters like the P. falciparum chloroquine resistance transporter (PfCRT), remains a significant challenge in targeting this complex (NCBI, 2023).
Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic free heme (ferriprotoporphyrin IX) which causes parasite membrane damage and death (Slater & Cerami, 1992, Nature; Egan, 2008, J Inorg Biochem).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum heme polymerization complex (PfHPC).